Periodontal disease and bacterial vaginosis as genetic and environmental markers for the risk of spontaneous preterm labor and preterm birth

References

• Lancucki L, editor. NHS Maternity Statistics, England: 1995–96 to 1997–98. London: Department of Health; 2001.
   Google Scholar
• Martin J.A, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep 2005;56: 1–103.
   Google Scholar
• Goldenberg RL, Hauth JC, Andrews WW. Mechanisms of disease: intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500–1507.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Jaggat AN. Emerging drug therapies for preventing spontaneous preterm labor and preterm birth. Expert Opin Investig Drugs 2007;16:337–345.
   PubMed Web of Science ®Google Scholar
• Jayasooriya GS, Lamont RF. The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth. Expert Opin Pharmacother 2009;10:1–10.
   PubMed Web of Science ®Google Scholar
• Howson CP, Merialdi M, Lawn JE, Requejo JH, Say L, editors. March of Dimes White paper on preterm birth: the global and regional toll. White plains, New York: The March of Dimes Foundation; 2009.
   Google Scholar
• Petrou S, Abangma G, Johnson S, Wolke D, Marlow N. Costs and health utilities associated with extremely preterm birth: evidence from the EPICure study. Value Health 2009;12:1124–1134.
   PubMed Web of Science ®Google Scholar
• Behrman RE, Butler AS, editors. Preterm birth: causes, consequences, and prevention. Institute of Medicine of the National AcademiesWashington, DC: National Academy Press; 2007.
   Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Pretorious C, Jagatt A, Lamont RF. The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 2007;35:93–99.
   PubMed Web of Science ®Google Scholar
• Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941–948.
   PubMed Web of Science ®Google Scholar
• Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival Plaque. J. Bacteriol 2001;183:3770–3783.
   PubMed Web of Science ®Google Scholar
• Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, Buchanan W, Bofill J, Papapanou PN, Mitchell DA, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006;355:1885–1894.
   PubMed Web of Science ®Google Scholar
• Oittinen J, Kurki T, Kekk M, Kuusisto M, Pussinen P, Vilkuna- Rautiainen T, Nieminen A, Asikainen S, Paavonen J. Periodontal disease and bacterial vaginosis increase the risk for adverse pregnancy outcome Infect Dis Obstet Gynecol 2005;13:213–216.
   PubMedGoogle Scholar
• Steel JH, Malato S, Kennea N, Edwards AD, Miles L, Duggan P, Reynolds PR, Feldman RG, Sullivan MH. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labour. Pediatr Res 2005;57:404–411.
   PubMed Web of Science ®Google Scholar
• Bearfield C, Davenport E, Sivapathasundaram V, Allaker R. Possible association between amniotic fluid microorganism infection and microflora in the mouth. BJOG 2002;109:527–533.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1998;31:553–584.
   Google Scholar
• Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labour versus indicated delivery. Am J Obstet Gynecol 1995;173:606–612.
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135–176.
   PubMed Web of Science ®Google Scholar
• Cassell G, Andrews W, Hauth J, Cutter G, Hamrick W, Baldus K, Waites K. Isolation of microorganisms from the chorioamnion is twice that from amniotic fluid at caesarean delivery in women with intact membranes. Am J Obstet Gynecol 1993;168:424.
   Google Scholar
• Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994;171:1660–1667.
   PubMed Web of Science ®Google Scholar
• Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997;30:93–109.
   Google Scholar
• Arntzen KJ, Kjollesdal AM, Halgunset J, Vatten L, Austgulen R. TNF, IL-1, IL-6, IL-8, and soluble TNF receptors in relation to chorioamnionitis and Preterm labor. J Perinat Med 1998;26:17–26.
   PubMed Web of Science ®Google Scholar
• Steinborn A, Kuhnert M, Halberstadt E. Immunomodulating cytokines induce term and preterm parturition. J Perinat Med 1996;24:381–390.
   PubMed Web of Science ®Google Scholar
• Maeda K, Matsuzaki N, Fuke S, Mitsuda N, Shimoya K, Nakayama M, Suehara N, Aono T. Value of the maternal interleukin 6 level for determination of histologic chorioamnionitis in preterm delivery. Gynecol Obstet Invest 1997;43:225–231.
   PubMed Web of Science ®Google Scholar
• Saito S, Kasahara T, Kato Y, Ishihara, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993;5: 81–88.
   PubMed Web of Science ®Google Scholar
• Stallmach T, Hebisch G, Joller H, Kolditz P, Engelmann M. Expression pattern of cytokines in the different compartment of the feto-maternal unit under various conditions. Reprod Fertil Dev 1995;7:1573–1580.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Sepulveda W, Avila C, Copel D, Williams J. Tumour necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166:1576–1587.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Narahara H, Takai J, Yoshimatsu T, Anai T, Miyakawa I. Interleukin-1 (beta) and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol 1998;179:644–649.
   PubMed Web of Science ®Google Scholar
• Hiroshige M, Kyoko K, Yasumasa S, Atsushi I, Teruhiko T. Preterm labor and bacterial intraamniotic infection: arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. Am J Obstet Gynecol 1998;179:1579–1582.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Anthony F, Myatt L, Booth L, Furr PM, Taylor-Robinson D. Production of prostaglandin E2 by human amnion in vitro in response to addition of media conditioned by microorganisms associated with chorioamnionitis and preterm labour. Am J Obstet Gynecol 1990;162:819–825.
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, Mazaki – Tovi S, Than NG, Hassan S, Tromp G. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 2006;113:118–135.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433–1440.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumour necrosis factor-alpha, interleukin-1 beta, and interlekin-8 and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825–830.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to an intraamniotic inflammatory and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675–681.
   PubMed Web of Science ®Google Scholar
• Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss A. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-enviroment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004;190:1504–1508.
   PubMed Web of Science ®Google Scholar
• Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of spontaneous preterm birth is associated with common pro- inflammatory cytokine polymorphisms. Epidemiology 2005;16:469–477.
   PubMed Web of Science ®Google Scholar
• Takashiba S, Narushi K. Gene polymorphisms in periodontal health and disease. Periodontol 2000. 2006;40:94–106.
   PubMed Web of Science ®Google Scholar
• Moore S, Ide M, Randhawa M, Walker JJ, Reid JG, Simpson NA. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG 2004;11:1125–1132.
   Google Scholar
• Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 1995;333:1737–1742.
   PubMed Web of Science ®Google Scholar
• Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Br Med J 1994;308:295–298.
   PubMed Web of Science ®Google Scholar
• Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899–1903.
   PubMed Web of Science ®Google Scholar
• Hill GB. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 1998;3:222–232.
   PubMedGoogle Scholar
• Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173–177.
   PubMed Web of Science ®Google Scholar
• Moore S, Ide M, Coward PY, Randhawa M, Borkowska E, Baylis R, Wilson RF.. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome. Br Dent J 2004;197:251–258.
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM, McKaig RG, Jared HL, Mauriello SM, Auten RL Jr, et al. Maternal periodontitis and prematurity, Part 1, Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164–174.
   PubMedGoogle Scholar
• Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, McKaig R, Beck J. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67:1103–1113.
   PubMed Web of Science ®Google Scholar
• Dasanayake AP. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann Periodontol 1998;3:206–212.
   PubMedGoogle Scholar
• Goepfert AR, Jeffcoat MK, Andrews WW, Faye- Petersen O, Cliver SP, Goldenberg RL, Hauth JC. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004;4:777–783.
   Google Scholar
• Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc 2001;132:875–880.
   PubMed Web of Science ®Google Scholar
• Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG 2006;113:135–142.
   PubMed Web of Science ®Google Scholar
• Rajapakse PS, Nagarathne M, Chandrasekra KB, Dasanayake AP. Periodontal disease and prematurity among non-smokoing Sri Lankan women. J Dent Res 2005;84:274–277.
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Boggess KA, Murtha AP, Jared HL, Lieff S, McKaig RG, Mauriello SM, Moss KL, Beck JD. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006;107:29–36.
   PubMed Web of Science ®Google Scholar
• Srinivas SK, Samuel MD, Stamilio DM, Clothier B, Jeffcoat MK, Parry S, Macones GA, Elovitz MA, Metlay J. Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol 2009;200:497.e1–497.e8.
   PubMed Web of Science ®Google Scholar
• Boggess KA, Moss K, Madianos P, Murtha AP, Beck J, Offenbacher S. Fetal immune response to oral pathogens and risk of preterm birth. Am J Obstet Gynecol 2005;193:1121–1126.
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Jared HL, O' Reilly PG, Wells SR, Salvi GE, Lawrence HP, Socransky SS, Beck JD. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 1998;3:233–250.
   PubMedGoogle Scholar
• Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Dore CJ, Hay PE, Taylor-Robinson D. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000;8:158–165.
   PubMedGoogle Scholar
• Duff P, Lee ML, Hillier SL, Herd LM, Krohn MA, Eschenbach DA. Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet.Gynecol. 1991;77:431–435.
   PubMed Web of Science ®Google Scholar
• Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345–347.
   PubMed Web of Science ®Google Scholar
• Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732–1736.
   PubMed Web of Science ®Google Scholar
• Joesoef MR, Hillier SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, Idajadi A, Utomo B. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527–1531.
   PubMed Web of Science ®Google Scholar
• McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157–167.
   PubMed Web of Science ®Google Scholar
• McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391–1397.
   PubMedGoogle Scholar
• Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999;106:652–657.
   PubMedGoogle Scholar
• Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534–540.
   PubMed Web of Science ®Google Scholar
• Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, Jouppil P. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 2000;107:1427–1432.
   PubMed Web of Science ®Google Scholar
• Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97:643–648.
   PubMed Web of Science ®Google Scholar
• Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487–493.
   PubMed Web of Science ®Google Scholar
• Porter K, Rambo D, Jazayeri M, and Prien S. Prospective randomized trial of once versus twice a day metronidazole vaginal in obstetrical identified with bacterial vaginosis. Am J Obstet Gynecol 2001;184:S166.
   Google Scholar
• Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D. Preterm labour – is bacterial vaginosis involved? S Afr Med J 2002;92:231–234.
   PubMed Web of Science ®Google Scholar
• Guaschino S, Ricci E, Franchi M, Frate GD, Tibaldi C, Santo DD, Ghezzi F, Benedetto C, Seta FD, Parazzini F. Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J Obstet Gynecol Reprod Biol 2003;110:149–152.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:516–522.
   PubMed Web of Science ®Google Scholar
• Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983–988.
   PubMed Web of Science ®Google Scholar
• Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329:371.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Fahraeus L, Carlsson B, Jakobsson T, Forsum U. Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 2006;113:629–637.
   PubMed Web of Science ®Google Scholar
• McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007;1:CD000262.
   Google Scholar
• Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2008;2:CD006178.
   Google Scholar
• Hutzal CE, Boyle EM, Kenyon SL, Nash JV, Winsor S, Taylor DJ, Kirpalani H. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 2008;199:620–628.
   PubMed Web of Science ®Google Scholar
• Simcox R, Sin WT, Seed PT, Briley A, Shennan AH. Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol 2007;47:368–377.
   PubMed Web of Science ®Google Scholar
• Lamont RF. Antibiotics used in women at risk of preterm birth. Am J Obstet Gynecol 2008;199:583–584.
   PubMed Web of Science ®Google Scholar
• Hay PE, Taylor-Robinson D, Lamont RF. Preterm premature rupture of membranes. Lancet 1996;347:203.
   PubMedGoogle Scholar
• Lamont RF. Infection and preterm labour. Br J Obstet Gynaecol. 1998;105:1339–1340.
   PubMedGoogle Scholar
• Lamont RF. Antibiotics for the prevention of preterm birth. N Engl J Med 2000;342:581–583.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Taylor-Robinson D, Hay PE. Antibiotics for adverse outcomes of pregnancy. Lancet 2001;358:1728–1729.
   PubMed Web of Science ®Google Scholar
• Lamont RF. Association between cerebral palsy and erythromycin. Lancet 2009;373:26.
   PubMed Web of Science ®Google Scholar
• Mason MR, Adrinkra PE, Lamont RF. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased risk: a randomised placebo-controlled double-blind trial. BJOG 2000;107:295–296.
   PubMedGoogle Scholar
• Lamont DF. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth. BJOG 2003; 110:788–789.
   PubMed Web of Science ®Google Scholar
• Lamont RF. The maternal fetal medicine network trial. Am J Obstet Gynecol 2005;193:306–307.
   PubMed Web of Science ®Google Scholar
• Workoski KA, Berman SM. Sexually transmitted disease treatment guidelines. MMWR Recomm Rep 2006;55:1–94.
   Google Scholar
• Barry AL, Thornsberry C, Jones RN. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. Antimicrob.Agents Chemother 1987;31:343–345.
   PubMed Web of Science ®Google Scholar
• Young RA, Gonzalez JP, Sorkin EM. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1989;37:8–41.
   PubMed Web of Science ®Google Scholar
• Hillier SL, Holmes KK. Bacterial Vaginosis. Sexually transmitted diseasesIn: Holmes KK, Markowitz LE, Spellacy W, Wiggins R, editors. New York: McGraw-Hill; 1990. pp 547–550.
   Google Scholar
• Spiegel CA, Eschenbach DA, Amsel R, Holmes KK. Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis 1983;148:817–822.
   PubMed Web of Science ®Google Scholar
• Spiegel CA. Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds. Antimicrob.Agents Chemother. 1987;31:249–252.
   PubMed Web of Science ®Google Scholar
• Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J.Invest Dermatol. 1978;70:51–55.
   PubMed Web of Science ®Google Scholar
• Hand WL, Hand DL, King-Thompson NL. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1990;34:863–870.
   PubMed Web of Science ®Google Scholar
• Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1994;105:308–316.
   PubMed Web of Science ®Google Scholar
• Mikasa K, Kita E, Sawaki M, Kunimatsu M, Hamada K, Konishi M, Kashiba S, Narita N. The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J Antimicrob Chemother 1992;30:339–348.
   PubMed Web of Science ®Google Scholar
• Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res 1989;15:527–533.
   PubMedGoogle Scholar
• Lamont RF, Jones BM, Mandal D, Hay PE, Sheehan M. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol 2003;11:181–189.
   PubMedGoogle Scholar
• McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol. 1994;84:343–348.
   PubMed Web of Science ®Google Scholar
• Ugwumadu A, Reid F, Hay P, Manyonda I. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol. 2004;104:114–119.
   PubMedGoogle Scholar
• Vermeulen GM, van Zwet AA, Bruinse HW. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. BJOG 2001;108:697–700.
   PubMedGoogle Scholar
• Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antimicrob Agents Chemother 2002;46:3995–3996.
   PubMed Web of Science ®Google Scholar
• Xiao JC, Xie LF, Fang SL, Gao MY, Zhu Y, Song LY, Zhong HM, Lun ZR. Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro. Parasitol Res 2006;100:123–130.
   PubMed Web of Science ®Google Scholar
• Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL, Jr., Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004;4:5.
   PubMed Web of Science ®Google Scholar
• De Backer E, Dubreuil L, Brauman M, Acar J, Vaneechoutte M. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin.Microbiol.Infect. 2010;16:470–472.
   PubMed Web of Science ®Google Scholar
• Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den BT, Riphagen I, Van Lierde S. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009;116:1315–1324.
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman SM. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44:S73–S76.
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Hovarth LB, Kuzevska I, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478–1486.
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899–1911.
   PubMed Web of Science ®Google Scholar
• Thies FL, Konig W, Konig B. Rapid characterization of the normal and disturbed vaginal microbiota by application of 16S rRNA gene terminal RFLP fingerprinting. J Med Microbiol 2007;56:755–761.
   PubMed Web of Science ®Google Scholar
• Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GG, Brigidi P. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol 2007;73:5731–5741.
   PubMed Web of Science ®Google Scholar
• Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004;150:2565–2573.
   PubMed Web of Science ®Google Scholar
• Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol 2008;74:4898–4909.
   PubMed Web of Science ®Google Scholar
• Wertz J, Isaacs-Cosgrove N, Holzman C, Marsh TL. Temporal shifts in microbial communities in nonpregnant African-American women with and without bacterial vaginosis. Interdiscip Perspect Infect Dis 2008;2008:181–253.
   Google Scholar
• Biagi E, Vitali B, Pugliese C, Candela M, Donders GG, Brigidi P. Quantitative variations in the vaginal bacterial population associated with asymptomatic infections:a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis 2009;28:281–285.
   PubMed Web of Science ®Google Scholar
• Haggerty CL, Totten PA, Ferris M, Martin DH, Hoferka S, Astete SG, Ondondo R, Norori J, Ness RB. Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect 2009; 85:242–248.
   PubMed Web of Science ®Google Scholar
• Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, Nelson K. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093–1097.
   PubMed Web of Science ®Google Scholar
• Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis 1999;29:1145–1150.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Platz-Christensen JJ, Dalaker K, Eriksson K, Fahraeus L, Irminger K, Jerve F, Stray-Pedersen B, Wolner- Hanssen P. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. Acta Obstet Gynecol Scand 2000;79:390–396.
   PubMed Web of Science ®Google Scholar
• Llahi-Camp JM, Rai R, Ison C, Regan L, Taylor-Robinson D. Association of bacterial vaginosis with a history of second trimester miscarriage. Human Reprod 1996;11:1575–1578.
   PubMed Web of Science ®Google Scholar
• Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya – Achola JO, Bwayo J, Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863–1868.
   PubMed Web of Science ®Google Scholar
• Oleen-Burkey MA, Hillier SL. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995;3:149–157.
   PubMedGoogle Scholar
• Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005;32:446–453.
   PubMed Web of Science ®Google Scholar
• Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999;319:220–223.
   PubMed Web of Science ®Google Scholar
• Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am 2003;30:685–694.
   PubMed Web of Science ®Google Scholar
• Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546–550.
   PubMed Web of Science ®Google Scholar
• Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699–1706.
   PubMed Web of Science ®Google Scholar
• Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet.Gynecol. 1990;75:52–58.
   PubMed Web of Science ®Google Scholar
• Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility. BJOG 2002;109:714–717.
   PubMed Web of Science ®Google Scholar
• Goplerud CP, Ohm MJ, Galask RP. Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium. Am.J.Obstet.Gynecol. 1976;126:858–868.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Taylor-Robinson D, Hay PE. Antibiotics for adverse outcomes of pregnancy. Lancet 2001;358:1728–1729.
   PubMed Web of Science ®Google Scholar
• Lamont RF. Association between cerebral palsy and erythromycin. Lancet 2009;373:26.
   PubMed Web of Science ®Google Scholar
• Mason MR, Adrinkra PE, Lamont RF. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased risk: a randomised placebo-controlled double-blind trial. BJOG 2000;107:295–296.
   PubMedGoogle Scholar
• Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992;79:75–80.
   PubMed Web of Science ®Google Scholar
• Shim SS, Romero R, Hong JS, Park CW, Jun JK, Kim BI, Yoon BH. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339–1345.
   PubMed Web of Science ®Google Scholar
• Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295–298.
   PubMed Web of Science ®Google Scholar
• Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173–177.
   PubMed Web of Science ®Google Scholar
• Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 1993;169:175–178.
   PubMed Web of Science ®Google Scholar
• McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol. 1994;170:1048–1059.
   PubMed Web of Science ®Google Scholar
• Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG II, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737–1742.
   PubMed Web of Science ®Google Scholar
• Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E, Andrews WW. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1995;173:1231–1235.
   PubMed Web of Science ®Google Scholar
• Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899–1903.
   PubMed Web of Science ®Google Scholar
• Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen J, Sundell G, Hosseini N, Hagberg H. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997;104:1398–1404.
   PubMedGoogle Scholar
• Gratacos E, Figueras F, Barranco M, Vila J, Cararach V, Alonso PL, Fortuny A. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand 1998;77:37–40.
   PubMed Web of Science ®Google Scholar
• Holst E, Goffeng AR, Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol 1994;32:176–186.
   PubMed Web of Science ®Google Scholar
• Eschenbach DA, Gravett MG, Chen KC, Hoyme UB, Holmes KK. Bacterial vaginosis during pregnancy. An association with prematurity and postpartum complications. Scand J Urol Nephrol Suppl 1984;86:213–222.
   PubMedGoogle Scholar
• McDonald HM, O'Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Prenatal microbiological risk factors associated with preterm birth. Br J Obstet Gynaecol 1992;99:190–196.
   PubMedGoogle Scholar
• Lamont RF. Bacterial vaginosis. Preterm birthIn: Critchley H, Bennett P, Thornton S, editors. London: RCOG Press; 2004. pp. 163–180.
   Google Scholar
• Berg TG, Philpot KL, Welsh MS, Sanger WG, Smith CV. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999;19:275–277.
   PubMedGoogle Scholar
• Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, Davis JK. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294–302.
   PubMed Web of Science ®Google Scholar
• Gerber S, Vial Y, Hohlfeld P, Witkin SS. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003;187:518–521.
   PubMed Web of Science ®Google Scholar
• Gray DJ, Robinson HB, Malone J, Thomson RB, Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111–117.
   PubMed Web of Science ®Google Scholar
• Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995;40:375–379.
   PubMed Web of Science ®Google Scholar
• Nguyen DP, Gerber S, Hohlfeld P, Sandrine G, Witkin SS. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004;32:323–326.
   PubMed Web of Science ®Google Scholar
• Perni SC, Vardhana S, Korneeva I, Tuttle SL, Paraskevas LR, Chasen ST, Kalish RB, Witkin SS. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004;191:1382–1386.
   PubMed Web of Science ®Google Scholar
• Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001;357:989–994.
   PubMed Web of Science ®Google Scholar
• Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319–1327.
   PubMed Web of Science ®Google Scholar
• Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol 1979;135:1086–1103.
   PubMed Web of Science ®Google Scholar
• Hoffman HJ, Bakketeig LS. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 1984;27:539–552.
   PubMed Web of Science ®Google Scholar
• Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006;113:65–74.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Dragovic B. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al. BJOG 2006;113:850–851.
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Taylor-Robinson D. Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 2006;113:1483.
   PubMedGoogle Scholar
• Mombelli A, Samaranayake LP. Topical and systemic antibiotics in the management of periodontal diseases. Int Dent J 2004;54:3–14.
   PubMed Web of Science ®Google Scholar
• Jeffcoat MK, Hauth JC, Geurs NC, Reddy MS, Cliver SP, Hodgkins PM, Goldenberg RL. Periodontal disease and preterm birth: results of a pilot intervention study. J Periodontol 2003;74:1214–1218.
   PubMed Web of Science ®Google Scholar
• Sedlacek MJ, Walker C. Antibiotic resistance in an in vitro subgingivial biofilm model. Oral Microbiol Immunol 2007;22:333–339.
   PubMedGoogle Scholar
• Lopez NJ, Smith PC, Gutierrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: a randomised controlled trial. J Periodontol 2002;73:911–924.
   PubMed Web of Science ®Google Scholar
• Lopez NJ, Da Silva I, Ipinza J, Gutierrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy associated gingivitis. J Periodontol 2005;76:2144–2153.
   PubMed Web of Science ®Google Scholar
• Polyzos NP, Polyzos IP, Mauri D, Tzioras S, Tsappi M, Cortinovis I, Casazza G. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomised trials. Am J Obstet Gynecol 2009;200:225–232.
   PubMed Web of Science ®Google Scholar